Bioequivalence of Metformin Under Fed Conditions After Administration of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Male and Female Volunteers, (an Open-label, Randomised, Single Dose, Two-way Crossover, Phase I Trial).
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2013
At a glance
- Drugs Linagliptin; Linagliptin/metformin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 02 Jul 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 02 Jul 2012 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 28 Jun 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.